Heron Therapeutics Inc (HRTX)

May 25, 2026

HRTX PE Ratio & Valuation, Is HRTX Overvalued - Intellectia AI

May 25, 2026

May 24, 2026

Acute care revenue growth helps Heron (HRTX) reaffirm 2026 guidance despite Q1 sales decline - MSN

May 24, 2026

May 19, 2026

Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright? - Insider Monkey

May 19, 2026

May 18, 2026

Heron Therapeutics (HRTX) price target decreased by 15.38% to 3.74 - MSN

May 18, 2026

May 16, 2026

Heron Therapeutics, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:HRTX) 2026-05-16 - Seeking Alpha

May 16, 2026

May 15, 2026

HRTX Stock Price, Quote & Chart | HERON THERAPEUTICS INC (NASDAQ:HRTX) - ChartMill

May 15, 2026

May 13, 2026

Heron outlines $173M-$183M 2026 net product sales outlook as it targets return to positive adjusted EBITDA - MSN

May 13, 2026

May 13, 2026

Adage Capital amendment shows 0% ownership in Heron Therapeutics (HRTX) - Stock Titan

May 13, 2026

May 13, 2026

Heron Therapeutics (HRTX) Quarterly Loss Revives Dilution Fears And Tests Profitability Narrative - Sahm

May 13, 2026

May 12, 2026

H.C. Wainwright Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $4 - Moomoo

May 12, 2026

May 12, 2026

Heron Therapeutics | 10-Q: Q1 2026 Earnings Report - Moomoo

May 12, 2026

May 12, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2026 Earnings Call Transcript - Insider Monkey

May 12, 2026

May 12, 2026

H.C. Wainwright Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Cuts Target Price to $4 - Moomoo

May 12, 2026

May 12, 2026

Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $3 - Moomoo

May 12, 2026

May 12, 2026

H.C. Wainwright cuts Heron Therapeutics stock price target on weak Q1 results - Investing.com

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 12, 2026

Heron (HRTX) Q1 2026 Earnings Call Transcript - AOL.com

May 12, 2026

May 12, 2026

Heron Therapeutics Backs 2026 Rev $173M-$183M >HRTX - Moomoo

May 12, 2026

May 12, 2026

Heron Therapeutics Inc (HRTX) Q1 2026 Earnings Call Highlights: Resilient Growth Amidst Challenges By GuruFocus - Investing.com Canada

May 12, 2026

May 12, 2026

Heron Therapeutics Q1 earnings call highlights - MSN

May 12, 2026

May 12, 2026

Heron Therapeutics Faces Tight Covenant Constraints That Threaten Liquidity and Strategic Flexibility - TipRanks

May 12, 2026

May 12, 2026

Heron Therapeutics 1Q Loss/Shr 4c >HRTX - Moomoo

May 12, 2026

May 11, 2026

Heron Therapeutics Signals Recovery Despite Soft Q1 - TipRanks

May 11, 2026

May 11, 2026

Heron Therapeutics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 11, 2026

May 11, 2026

Heron Therapeutics, Inc. Form 10-Q: Financial Results, Forward-Looking Statements, and Key Risks for Q1 2026 - Minichart

May 11, 2026

May 11, 2026

Heron Therapeutics (NASDAQ:HRTX) Releases Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat

May 11, 2026

May 11, 2026

Heron Therapeutics, Inc. Reaffirms Earnings Guidance for the Full Year 2026 - marketscreener.com

May 11, 2026

May 11, 2026

Heron Therapeutics Q1 2026 Earnings Call Transcript - MarketBeat

May 11, 2026

May 11, 2026

Heron Therapeutics (HRTX) reports Q1 loss, lags revenue estimates - MSN

May 11, 2026

May 11, 2026

Heron Therapeutics Q1 Earnings Call Highlights - MarketBeat

May 11, 2026

May 11, 2026

Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline - Yahoo Finance

May 11, 2026

May 11, 2026

Heron Therapeutics Reports Q1 2026 Results: 32% Acute Care Revenue Growth, Reaffirms 2026 Guidance - Minichart

May 11, 2026

May 11, 2026

HRTX: Q1 sales reached $34.7M, rebounding in March, with strong growth and full-year guidance reaffirmed - TradingView

May 11, 2026

May 11, 2026

HRTX: Q1 sales hit $34.7M, acute care up 32% YoY, guidance reaffirmed, and commercial expansion planned - TradingView

May 11, 2026

May 11, 2026

Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 11, 2026

May 11, 2026

Earnings call transcript: Heron Therapeutics Q1 2026 results miss forecasts, stock drops - Investing.com Canada

May 11, 2026

May 11, 2026

Heron Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 11, 2026

May 11, 2026

Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance

May 11, 2026

May 11, 2026

Heron Therapeutics Q1 Results Miss, but Acute Care Growth and Reaffirmed Outlook Support HRTX - ChartMill

May 11, 2026

May 11, 2026

Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 11, 2026

May 11, 2026

Heron Therapeutics Q1 2026 earnings preview - MSN

May 11, 2026

May 11, 2026

Heron Therapeutics' Q1 revenue falls as oncology sales drop - TradingView

May 11, 2026

May 11, 2026

HERON THERAPEUTICS, INC. /DE/ 1Q 2026: Revenue $34.7M, EPS $(0.04) — 10-Q Summary - TradingView

May 11, 2026

May 11, 2026

Heron Therapeutics: Q1 Earnings Snapshot - kare11.com

May 11, 2026

May 11, 2026

Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance - The Manila Times

May 11, 2026

May 11, 2026

BRIEF-Heron Therapeutics Q1 EPS USD -0.04 - TradingView

May 11, 2026

May 11, 2026

Heron Therapeutics (HRTX) swings to Q1 2026 loss as oncology sales fall and interest costs rise - Stock Titan

May 11, 2026

May 11, 2026

[8-K] HERON THERAPEUTICS, INC. /DE/ Reports Material Event - Stock Titan

May 11, 2026